Development and validation of bio-analytical method for the quantitative estimation of rivaroxaban by using UV spectrophotometry
Keywords:
Rivaroxaban, USFDA guidelinesAbstract
The present study deals with the development and validation of bioanalytical method for the quantitative estimation of rivaroxaban by using UV spectrophotometric technique. Maximum absorption of 250 nm, was selected for the analysis and the drug obeyed Beer-Lambert’s law in the concentration range of 1000-7000ng/ml. Coefficient of correlation for linearity was found to be 0.995. The developed method has been validated for accuracy and precision as per USFDA guidelines. LLOQ, LQC, MQC and HQC values were found to be within the acceptable limits. The developed method was successfully applied for determination of rivaroxaban in spiked rat plasma with good recovery.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.